Premium
Programmed cell death ligand 1 as a biomarker in head and neck cancer
Author(s) -
Pai Sara I.,
Faquin William C.
Publication year - 2017
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.21872
Subject(s) - medicine , head and neck cancer , head and neck , biomarker , programmed cell death 1 , ligand (biochemistry) , cancer , programmed cell death , oncology , cancer research , immune checkpoint , pd l1 , immunotherapy , apoptosis , surgery , receptor , biochemistry , chemistry
The evaluation of programmed cell death ligand 1 has a potential role in the application of immune checkpoint inhibitors for select cancers of the head and neck. See also pages 521‐8.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom